the aid library

LIST OPTIONS

Filter

8066

Access to Heart Failure Medicines in Low- and Middle-Income Countries: An Analysis of Essential Medicines Lists, Availability, Price, and Affordability

Agarwal, A.; Husain, M.J.; Datta, B. et al. Circulation: Heart Failure (2022) CC

Heart failure (HF) is a leading global public health problem with >64 million prevalent cases globally. Patients with HF with reduced ejection fraction (HFrEF) from low- and middle-income countries experience a 22% to 58% higher 1-year mortality rate than those in high-income countries.1 Guideline-d... more

External Link

Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review

Wright J.E., Werkman M., Dunn J.C. et al Parasites and Vectors (2018) C2

Background: The human helminth infections include ascariasis, trichuriasis, hookworm infections, schistosomiasis, lymphatic filariasis (LF) and onchocerciasis. It is estimated that almost 2 billion people worldwide are infected with helminths. Whilst the WHO treatment guidelines for helminth infecti...ons are mostly aimed at controlling morbidity, there has been a recent shift with some countries moving towards goals of disease elimination through mass drug administration, especially for LF and onchocerciasis. However, as prevalence is driven lower, treating entire populations may no longer be the most efficient or cost-effective strategy. Instead, it may be beneficial to identify individuals or demographic groups who are persistently infected, often termed as being “predisposed” to infection, and target treatment at them. Methods: The authors searched Embase, MEDLINE, Global Health, and Web of Science for all English language, humanbased papers investigating predisposition to helminth infections published up to October 31st, 2017. The varying definitions used to describe predisposition, and the statistical tests used to determine its presence, are summarised. Evidence for predisposition is presented, stratified by helminth species, and risk factors for predisposition to infection are identified and discussed. Results: In total, 43 papers were identified, summarising results from 34 different studies in 23 countries. Consistent evidence of predisposition to infection with certain species of human helminth was identified. Children were regularly found to experience greater predisposition to Ascaris lumbricoides, Schistosoma mansoni and S. haematobium than adults. Females were found to be more predisposed to A. lumbricoides infection than were males. Household clustering of infection was identified for A. lumbricoides, T. trichiura and S. japonicum. Ascaris lumbricoides and T. trichiura also showed evidence of familial predisposition. Whilst strong evidence for predisposition to hookworm infection was identified, findings with regards to which groups were affected were considerably more varied than for other helminth species. Conclusion: This review has found consistent evidence of predisposition to heavy (and light) infection for certain human helminth species. However, further research is needed to identify reasons for the reported differences between demographic groups. Molecular epidemiological methods associated with whole genome sequencing to determine ‘who infects whom’ may shed more light on the factors generating predisposition. more

External Link

External Link (413)

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi...lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

External Link

External Link (337)

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double- blind, randomised, phase 3 trial

Datoo, M.S.; A. Dicko, H.Tinto, et al. (2024) CC

Lancet 2024; 403: 533–44 R21/Matrix-M was well tolerated and offered high efficacy against clinical malaria in African children. This low-cost, high-efficacy vaccine is already licensed by several African countries, and recently received a WHO policy recommendation and prequalification, offerin... more

Download (466)

View PDF (414)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (346)

View PDF (520)

The impact of transition from global fund support to governmental funding on the sustainability of harm reduction programs

S. Ibisevic; G. Shaw; Dr. S. Godinjak; Dr. Z. Cardaklija; et al. Eurasian Harm Reduction Network; ICASO (2016) C2

A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw. EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson... more

Download (963)

View PDF (1550)

Integrated surveillance of antimicrobial resistance in foodborne bacteria

World Health Organization WHO (2017) C_WHO

Application of a One Health approach . The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan... more

External Link

Formation spécifique aux vaccins contre la COVID-19

Open WHO; World Health Organization WHO (2022) C_WHO

L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des ... more

Download (594)

View PDF (516)

Credits Vaccination préventive du cheptel contre le charbon au Mali

World Health Organisation (WHO) (2023) C2

L'anthrax est une maladie bactérienne, causée par Bacillus anthracis, qui peut se transmettre des animaux herbivores à l'homme par contact étroit, en mangeant de la viande d'animaux infectés, ou par contamination environnementale. L'anthrax peut être une maladie grave nécessitant un diagnos... more

Download (805)

View PDF (1284)

Field use of molluscicides in schistosomiasis control programmes: an operational manual for programme managers

World Health Organization (WHO) (2017) C_WHO

Recent systematic reviews and meta-analysis of the impact of chemical-based mollusciciding (King et al., 2015, Sokolow et al., 2016) have concluded that regular mollusciciding is likely to contribute significantly towards elimination of schistosomiasis in high-risk areas. The WHO roadmap’s new foc... more

Download (468)

View PDF (374)

Plan national de developpement sanitaire (PDNS 4) 2022-2030

World Health Organisation (WHO) (2022) C_WHO

Le Ministère de la Santé Publique et de la Prévention en collaboration avec les partenaires techniques et financiers, a procédé à l’élaboration du Plan National de Développement Sanitaire quatrième de la Génération (PNDS4), couvrant la période 2022-2030. Ce PNDS4, contrairement aux PND... more

Download (581)

View PDF (392)

Task sharing and task shifting: Optimizing the primary health care workforce for improved delivery of noncommunicable disease services in Kenya

World Health Organisation (WHO) (2024) C_WHO

Over one third of all deaths in Kenya in 2019 were attributed to NCDs (Vos et al., 2020). The four major NCDs – CVDs, cancer, diabetes and chronic respiratory diseases – accounted for 57% of these deaths. Furthermore, the direct and indirect economic impact of NCDs is significant- Kenya is sai... more

Download (519)

View PDF (469)

Lignes directrices provisoires pour la surveillance du choléra

Global Task Force on Cholera Control (GTFCC) World Health Organization WHO (2017) C_WHO

Le choléra reste une menace mondiale pour la santé publique et un indicateur clé du manque de développement social. La transmission du choléra est étroitement liée à l’accès insuffisant à l’eau potable et à l’assainissement. Les zones typiques à risque sont notamment les bido... more

Download (421)

View PDF (380)

Approche axée sur les personnes pour lutter contre la résistance aux antimicrobiens dans le secteur de la santé humaine

World Health Organisation (WHO) (2024) C_WHO

La résistance aux antimicrobiens (RAM) est une réponse évolutive naturelle à l’exposition aux antimicrobiens, qui a été aggravée par des comportements humains, tels que l’utilisation abusive et excessive d’antimicrobiens, l’utilisation d’antimicrobiens dans l’agriculture et la... more

External Link

Bon usage des antibiotiques: une approche par compétences

World Health Organization WHO (2016) C_WHO

Ce cours donnera aux cliniciens qui prescrivent régulièrement des antibiotiques les connaissances et les outils pour améliorer l’utilisation de ces médicaments essentiels dans la pratique clinique quotidienne. A l’aide d’exemples de cas, le cours mettra en évidence la façon dont les prin... more

External Link

Trématodoses d’origine alimentaire - French version

World Health Organization World Health Organization WHO (2023) C_WHO

Website last accessed on 14.04.2023 Les trématodes d'origine alimentaire sont des zoonoses et leurs agents pathogènes ne peuvent être transmis à l'homme qu'après avoir accompli un cycle de vie complexe, dont certaines étapes se déroulent dans un hôte animal intermédiaire. Les premiers h... more

Download (386)

View PDF (502)

Rapport annuel 2023

World Health Organization WHO (2024) C_WHO

En 2023, la nouvelle stratégie de Coopération de l’OMS avec le Niger 2023-2027 a été lancée, assortie d’un plan d’investissement. En outre, l’OMS a soutenu plusieurs initiatives majeures du pays, comme le lancement effectif de la Stratégie nationale de la Couverture Sanitaire Universel... more

External Link

Live life : Guide pratique pour la prévention du suicide dans les pays

World Health Organisation (WHO) (2022) C_WHO

Plus de 700 000 personnes perdent la vie par suicide chaque année. La réduction d’un tiers du taux mondial de mortalité par suicide d’ici à 2030 est à la fois un indicateur et une cible (la seule pour la santé mentale) dans les objectifs de développement durable des Nations Unies et dans ... more